Moses T. Bility

1.6k citations

30 papers · 1.3k indexed · 1 hit paper · h-index 17

Co-authors: Lishan Su Frank J. Gonzalez Jeffrey M. Peters Liguo Zhang Kovalev Gi Michael L. WashburnFeng LiAndrew N. Billin
Topics: Peroxisome Proliferator-Activated Receptors (10 papers)Liver Disease Diagnosis and Treatment (7 papers)Hepatitis C virus research (6 papers)
Cited by: Hepatology Cancer Research Epidemiology
Journals: Gastroenterology Molecular and Cellular Biology Hepatology
Partner nations: United States China Thailand

In The Last Decade

Moses T. Bility

30 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease

2011 220 citations Michael L. Washburn, Moses T. Bility et al. Gastroenterology profile →

Peers

Countries citing papers authored by Moses T. Bility

Since Specialization

Citations

This map shows the geographic impact of Moses T. Bility's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moses T. Bility with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moses T. Bility more than expected).

Fields of papers citing papers by Moses T. Bility

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moses T. Bility. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moses T. Bility. The network helps show where Moses T. Bility may publish in the future.

Co-authorship network of co-authors of Moses T. Bility

This figure shows the co-authorship network connecting the top 25 collaborators of Moses T. Bility. A scholar is included among the top collaborators of Moses T. Bility based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moses T. Bility. Moses T. Bility is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can Humanized Immune System Mouse and Rat Models Accelerate the Development of Cytomegalovirus-Based Vaccines Against Infectious Diseases and Cancers? 2025 ·International Journal of Molecular Sciences ·(unknown),(unknown),I.T.R. Barnett,Craig Donaldson,Ignacio Anegón,Srinivas Madduri,Qiyi Tang,Moses T. Bility	3
2	Nef defect attenuates HIV viremia and immune dysregulation in the bone marrow-liver-thymus-spleen (BLTS) humanized mouse model 2024 ·Virology ·(unknown),(unknown),Antu Das,Sherry T. Shu,Jasmine Samal,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Robbie B. Mailliard,Thomas E. Smithgall,Moses T. Bility	5
3	The BLT Humanized Mouse Model as a Tool for Studying Human Gamma Delta T Cell-HIV Interactions In Vivo 2022 ·Frontiers in Immunology ·(unknown),(unknown),Michael T. Lotze,Moses T. Bility,Robbie B. Mailliard	7
4	Author Correction: Development of humanized mouse and rat models with full-thickness human skin and autologous immune cells 2021 ·Scientific Reports ·(unknown),(unknown),(unknown),Lance R. Thurlow,Antu Das,Samantha Kelly,(unknown),(unknown),(unknown),(unknown),Anthony R. Richardson,Moses T. Bility	3
5	Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies 2020 ·Retrovirology ·(unknown),(unknown),(unknown),(unknown),(unknown),Kevin Melody,Moses T. Bility	14
6	Development of humanized mouse and rat models with full-thickness human skin and autologous immune cells 2020 ·Scientific Reports ·(unknown),(unknown),(unknown),Lance R. Thurlow,Antu Das,Samantha Kelly,(unknown),(unknown),(unknown),(unknown),Anthony R. Richardson,Moses T. Bility	18
7	Perceived barriers and supports to accessing community-based services for Uganda’s pediatric post-surgical population 2019 ·Disability and Rehabilitation ·(unknown),Sahil Sandhu,(unknown),(unknown),(unknown),(unknown),Emily R. Smith,Brittney van de Water,(unknown),(unknown),(unknown),(unknown),(unknown),Moses T. Bility,Janet Prvu Bettger	5
8	Availability of post-hospital services supporting community reintegration for children with identified surgical need in Uganda 2018 ·BMC Health Services Research ·Emily R. Smith,Brittney van de Water,(unknown),(unknown),(unknown),(unknown),Moses T. Bility,(unknown),João Ricardo Nickenig Vissoci,Michael M. Haglund,Janet Prvu Bettger	12
9	Chronic hepatitis C infection–induced liver fibrogenesis is associated with M2 macrophage activation 2016 ·Scientific Reports ·Moses T. Bility,Kouki Nio,Feng Li,David R. McGivern,Stanley M. Lemon,Eoin R. Feeney,Raymond T. Chung,Lishan Su	56
10	Modeling hepatitis B virus infection, immunopathology and therapy in mice 2015 ·Antiviral Research ·Liang Cheng,Feng Li,Moses T. Bility,(unknown),Lishan Su	24
11	Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes 2014 ·Carcinogenesis ·Michael G. Borland,K. C. Prasad,Christina Lee,(unknown),Weiwei Shan,Moses T. Bility,Craig B. Marcus,Jyh Ming Lin,Shantu Amin,Frank J. Gonzalez,Gary H. Perdew,Jeffrey M. Peters	24
12	A Chimeric Mouse Model to Study Immunopathogenesis of HCV Infection 2014 ·Methods in molecular biology ·Moses T. Bility,(unknown),Lishan Su	4
13	Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages 2014 ·PLoS Pathogens ·Moses T. Bility,Liang Cheng,Zheng Zhang,Yan Luan,Feng Li,Liqun Chi,Liguo Zhang,Zhengkun Tu,Yanhang Gao,Yang‐Xin Fu,Junqi Niu,Fusheng Wang,Lishan Su	188
14	Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis 2012 ·Nature Protocols ·Moses T. Bility,Liguo Zhang,Michael L. Washburn,(unknown),Kovalev Gi,Lishan Su	60
15	A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Diseasebreakdown → 2011 ·Gastroenterology ·Michael L. Washburn,Moses T. Bility,Liguo Zhang,Kovalev Gi,Adam Buntzman,J. A. Frelinger,(unknown),Alexander Ploß,Charles M. Rice,Lishan Su	220
16	Ligand Activation of Peroxisome Proliferator–Activated Receptor-β/δ and Inhibition of Cyclooxygenase-2 Enhances Inhibition of Skin Tumorigenesis 2009 ·Toxicological Sciences ·Moses T. Bility,Bokai Zhu,(unknown),Frank J. Gonzalez,Jeffrey M. Peters	31
17	Ligand activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) inhibits chemically induced skin tumorigenesis 2008 ·Carcinogenesis ·Moses T. Bility,Meghann K Devlin-Durante,Nicholas Blazanin,Adam B. Glick,Jerrold M. Ward,(unknown),Mary J. Kennett,Frank J. Gonzalez,Jeffrey M. Peters	33
18	Ligand activation of peroxisome proliferator-activated receptor-β/δ(PPARβ/δ) inhibits cell growth of human N/TERT-1 keratinocytes 2007 ·Cellular Signalling ·Andrew D. Burdick,Moses T. Bility,(unknown),Andrew N. Billin,Timothy M. Willson,Frank J. Gonzalez,Jeffrey M. Peters	71
19	Peroxisome proliferator-activated receptor-β/δ protects against chemically induced liver toxicity in mice 2007 ·Hepatology ·Weiwei Shan,Christopher J.B. Nicol,Shinji Ito,Moses T. Bility,Mary J. Kennett,Jerrold M. Ward,Frank J. Gonzalez,Jeffrey M. Peters	79
20	Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (PPARs) by Phthalate Monoesters 2004 ·Toxicological Sciences ·Moses T. Bility	192

About Moses T. Bility

Moses T. Bility is a scholar working on Virology, Hepatology and Immunology, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (10 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis C virus research (6 papers). The work is most often cited by research in Hepatology (330 citations), Cancer Research (197 citations) and Epidemiology (407 citations). Moses T. Bility has collaborated with scholars based in United States, China and Thailand. Frequent co-authors include Lishan Su, Frank J. Gonzalez, Jeffrey M. Peters, Liguo Zhang, Kovalev Gi, Michael L. Washburn, Feng Li, Andrew N. Billin, Timothy M. Willson and Liang Cheng. Their work appears in journals such as Gastroenterology, Molecular and Cellular Biology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact